We have located links that may give you full text access.
1D.06: LONGITUDINAL EVALUATION OF CARDIOVASCULAR RISK AFTER PEDIATRIC KIDNEY TRANSPLANTATION.
Journal of Hypertension 2015 June
OBJECTIVE: Children with chronic kidney disease (CKD) carry an increased cardiovascular risk. Cardiovascular death is the second leading cause of death in children after renal transplantation. The 4C-T (Cardiovascular Comorbidity in Children with CKD and Transplantation) study evaluates cardiovascular target organ damage longitudinally in children prior to and after renal transplantation.
DESIGN AND METHOD: The multicenter, prospective, observational 4C study enrolled 736 children aged 6 to 17 years with estimated GFR <40 ml/min/1.73 m2 at 55 Pediatric Nephrology centres from 12 European countries. Of these, 226 have started renal replacement therapy (RRT) and entered the 4C-T sub-study. At annual study visits, the morphology and function of the heart and large arteries were monitored by noninvasive methods.
RESULTS: 176 of the 226 patients on RRT had at least one visit after RRT start and were included in this analysis. 70 patients had started dialysis and 106 received a transplant. 62% of the patients were transplanted pre-emptively. Overall patients carried a higher cardiovascular risk compared to the age-matched general population as documented by elevated age-adjusted aortic pulse wave velocity (PWV) and carotid intima-media thickness (IMT). Factors determining PWV, IMT and left ventricular mass index (LVMI) were analysed using mixed longitudinal modelling (table).(Figure is included in full-text article.)
CONCLUSIONS: : Our data is consistent with the hypothesis that transplantation lowers cardiovascular risk. Mixed modeling allowed to decipher the positive effect of transplantation from interfering cardiovascular risk factors such as hypertension, hypercholesterolemia and PTH.
DESIGN AND METHOD: The multicenter, prospective, observational 4C study enrolled 736 children aged 6 to 17 years with estimated GFR <40 ml/min/1.73 m2 at 55 Pediatric Nephrology centres from 12 European countries. Of these, 226 have started renal replacement therapy (RRT) and entered the 4C-T sub-study. At annual study visits, the morphology and function of the heart and large arteries were monitored by noninvasive methods.
RESULTS: 176 of the 226 patients on RRT had at least one visit after RRT start and were included in this analysis. 70 patients had started dialysis and 106 received a transplant. 62% of the patients were transplanted pre-emptively. Overall patients carried a higher cardiovascular risk compared to the age-matched general population as documented by elevated age-adjusted aortic pulse wave velocity (PWV) and carotid intima-media thickness (IMT). Factors determining PWV, IMT and left ventricular mass index (LVMI) were analysed using mixed longitudinal modelling (table).(Figure is included in full-text article.)
CONCLUSIONS: : Our data is consistent with the hypothesis that transplantation lowers cardiovascular risk. Mixed modeling allowed to decipher the positive effect of transplantation from interfering cardiovascular risk factors such as hypertension, hypercholesterolemia and PTH.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app